PIN1 and neoplasm: Importantly, ATO and ATRA co-treatment not only effectively reduced breast TIC frequency by ~90-fold (P < 0.0001), but also dramatically reduced tumor growth (Fig. 7f and Table 1), similar to Pin1 KO (Fig. 7g and Table 1).